Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

According to the National Cancer Institute, approximately 40.5% of Americans will be diagnosed with cancer at some point ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...

A Rockton woman is accused of stealing a Visa gift card from a resident of an assisted living facility in Janesville.

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

The incidence of mental illness was higher among women with MS during both the prenatal period (incidence ratio [IR] 1.26, 95 ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

The FDA reported that six patients died after being injected with Teva’s Copaxone or Sandoz’s Glatopa. The US Food and Drug ...

After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.